We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Fund
S&P 500
This Quarter
Est. Return
-5.2%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$176M
AUM Growth
-$3.89M
(-2.2%)
Cap. Flow
+$11.2M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
22.1%
Holding
256
New
24
Increased
39
Reduced
133
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$3.86M |
| 2 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$3.65M |
| 3 |
TSVT
2seventy bio
TSVT
|
+$3.13M |
| 4 |
uniQure
QURE
|
+$3.1M |
| 5 |
Embecta
EMBC
|
+$2.13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$3.44M |
| 2 |
Elanco Animal Health
ELAN
|
+$2.97M |
| 3 |
Centene
CNC
|
+$2.7M |
| 4 |
iShares MBS ETF
MBB
|
+$2.05M |
| 5 |
Lantheus
LNTH
|
+$1.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 61.71% |
| 2 | Real Estate | 10.29% |
| 3 | Financials | 3.55% |
| 4 | Technology | 3.29% |
| 5 | Energy | 2.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
MGM Resorts International
MGM
$11.9B
| $171K | 0.1% |
4,659
-631
| -12% | -$27.9K |
|
152
American Airlines Group
AAL
$10B
| $168K | 0.1% |
13,142
-1,769
| -12% | -$27.5K |
|
153
Hershey
HSY
$34.8B
| $167K | 0.09% |
834
-28
| -3% | -$6.27K |
|
154
Uber
UBER
$147B
| $152K | 0.09% |
3,307
-564
| -15% | -$25.8K |
|
155
The Mosaic Company
MOS
$7.12B
| $151K | 0.09% |
4,255
-570
| -12% | -$21.9K |
|
156
Cenovus Energy
CVE
$52.7B
| $146K | 0.08% |
7,003
-1,144
| -14% | -$21.8K |
|
157
iShares MSCI Turkey ETF
TUR
$207M
| $145K | 0.08% |
3,764
+921
| +32% | +$32.2K |
|
158
iShares MSCI India ETF
INDA
$6.78B
| $142K | 0.08% |
3,207
-135
| -4% | -$5.97K |
|
159
iShares MSCI Brazil ETF
EWZ
$8.98B
| $140K | 0.08% |
4,571
-265
| -5% | -$8.42K |
|
160
Microbot Medical
MBOT
$120M
| $139K | 0.08% |
100,000
| – | – |
|
161
CALL
United Rentals
URI
$63.4B
| $138K | 0.08% |
310
-32
| -9% | -$14.6K |
|
162
iShares MSCI Taiwan ETF
EWT
$9.8B
| $138K | 0.08% |
3,093
+76
| +3% | +$3.52K |
|
|
ASXC
163
DELISTED
Asensus Surgical, Inc.
ASXC
| $135K | 0.08% |
500,000
| – | – |
|
164
Diamondback Energy
FANG
$55B
| $133K | 0.08% |
860
-87
| -9% | -$12.8K |
|
165
iShares MSCI Mexico ETF
EWW
$1.88B
| $133K | 0.08% |
2,287
-42
| -2% | -$2.6K |
|
166
iShares MSCI Peru and Global Exposure ETF
EPU
$528M
| $133K | 0.08% |
4,403
-333
| -7% | -$10.6K |
|
167
EOG Resources
EOG
$75.1B
| $131K | 0.07% |
1,036
-169
| -14% | -$21.5K |
|
|
KRTX
168
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $127K | 0.07% |
+750
| New | +$141K |
|
169
iShares MSCI Poland ETF
EPOL
$661M
| $126K | 0.07% |
7,364
-844
| -10% | -$16.2K |
|
170
Hewlett Packard
HPE
$59B
| $126K | 0.07% |
7,249
-720
| -9% | -$12.4K |
|
|
GREK
171
Global X MSCI Greece ETF
GREK
$279M
| $125K | 0.07% |
3,753
-346
| -8% | -$12.8K |
|
172
iShares MSCI United Kingdom ETF
EWU
$3.97B
| $124K | 0.07% |
3,917
+33
| +0.8% | +$1.06K |
|
|
PXD
173
DELISTED
Pioneer Natural Resource Co.
PXD
| $122K | 0.07% |
531
-57
| -10% | -$13K |
|
174
iShares MSCI Spain ETF
EWP
$1.95B
| $121K | 0.07% |
4,402
-183
| -4% | -$5.19K |
|
175
iShares MSCI Italy ETF
EWI
$908M
| $119K | 0.07% |
3,905
-269
| -6% | -$8.57K |
|
Similar funds
WCM
FCM
BIA
AGAM
E
HCM
AC
OIS
AlphaCentric Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, AlphaCentric Advisors held 256 positions worth $176M, down 2.2% from $180M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
AlphaCentric Advisors deployed $11.2M of net new capital in Q3 2023, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
By sector, the portfolio is most concentrated in Healthcare at 62% of assets, up from 60% a quarter earlier, followed by Real Estate and Financials.
On the sell side, the largest reduction was Jazz Pharmaceuticals, an estimated $1.9M trimmed.
- AlphaCentric Advisors's largest Q3 2023 buy was Revance Therapeutics, Inc.: 190,000 shares worth $2.18M.
- AlphaCentric Advisors added most to Walgreens Boots Alliance in Q3 2023, an estimated $3.86M increase.
- AlphaCentric Advisors's biggest Q3 2023 reduction was Jazz Pharmaceuticals, cutting an estimated $1.9M.
- AlphaCentric Advisors fully exited AdaptHealth in Q3 2023, selling an estimated $3.44M.
- AlphaCentric Advisors's ten largest holdings make up 22% of its $176M portfolio in Q3 2023.
- AlphaCentric Advisors opened 24 new positions and closed 21 in Q3 2023.
- AlphaCentric Advisors's portfolio value fell 2.2% quarter-over-quarter to $176M.
Based on AlphaCentric Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.